June 20, 2024 C-Path Partners with FARA to Fortify RDCA-DAP and Further Accelerate Drug Development with new Friedreich’s Ataxia Data C-Path announced the targeted integration of additional Friedreich’s ataxia...
June 12, 2024 C-Path’s AI Collaborations Accelerate Drug Development, Improve Lives Critical Path Institute (C-Path) today announced the publication of a new peer-reviewed paper in the journal Clinical and...
June 12, 2024 C-Path’s Parkinson’s Consortium Supports Groundbreaking Research Utilizing Smartwatches to Monitor Disease Progression Critical Path Institute (C-Path) today announced a new publication on how the use of wearable technology...
May 15, 2024 NEW FUNDING OPPORTUNITY! C-Path’s TRxA Announces its First Biologics-focused RFP for Academic Investigators C-Path Translational Therapeutics Accelerator (TRxA) today announced its inaugural biologics-focused Request for Proposals (RFP)..
May 9, 2024 C-Path’s CDRC and xCures Partner with Lane United Football Club and hummel for United Against Cancer Games C-Path) is excited to announce a collaboration between Lane United Football Club (LUFC), xCures, and the nonprofits...
May 7, 2024 C-Path’s International Neonatal Consortium and the National Association of Neonatal Nurses Open Access to Neonatal Drug Development Education Modules C-Path today announced the launch of its continuing education (CE) neonatal drug development modules — a collaboration....
C-Path Forms Data Collaboration with International Niemann-Pick Disease Registry (INPDR) to Propel Niemann-Pick Disease Research Forward TUCSON, Ariz. April 17, 2024 — Critical Path Institute (C-Path), a leader in advancing rare disease research, today announced a
C-Path Appoints Dr. Amanda Klein as Executive Director for CPLD and CPA-1 Consortia TUCSON, Ariz., April 17, 2024 — Critical Path Institute (C-Path) today announced the appointment of Amanda Klein, Pharm.D., as E
April 10, 2024 Critical Path Institute Announces New Board Members Bonnie A. Allin and Louis Breton Critical Path Institute (C-Path) today announced the appointments of Bonnie A. Allin and Louis Breton to its Board of Directors.
March 28, 2024 C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of...
